Heartflow

HTFL · NASDAQ

$55.59+$4.57 (+8.96%)TodayMarket closed ·
Prev close $51.02

Latest news

  • News

    10 Health Care Stocks With Whale Alerts In Today’s Session

  • NewsHenry Khederian

    HeartFlow Shares Soar Following Strong Q2 Results and Upgraded Guidance

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    HeartFlow Q2 2026 Earnings Call Transcript

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

  • Press releasePRNewswire

    16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap

  • News

    Transcript: HeartFlow Q1 2026 Earnings Conference Call

  • Press releaseGlobe Newswire

    Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

  • News

    Earnings Scheduled For May 14, 2026

  • Press releaseGlobe Newswire

    A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech

  • Press releaseGlobe Newswire

    The Future of Intoxication Detection May Be in Your Voice

  • NewsPiero Cingari

    Earnings Volatility Watch: 10 Stocks With More Than 17% Implied Moves This Week

  • Press releaseGlobe Newswire

    The Quiet Shift Replacing Million-Dollar Heart Scanners With Software

  • Press releasePRNewswire

    How Decentralized AI is Unlocking Value in Cardiac Diagnostics

  • Press releaseGlobe Newswire

    Heartflow Reports Fourth Quarter and Full Year 2025 Financial Results

  • News

    Earnings Scheduled For March 18, 2026

  • Press releaseGlobe Newswire

    AI Diagnostics: The End of the High-Cost Imaging Era

  • Press releasePRNewswire

    AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs

  • News

    Earnings Scheduled For November 12, 2025

  • Press releaseBusiness Wire

    Calyxo Expands Board of Directors as Number of Patients Treated with its CVAC® System Crosses 20,000 Milestone

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.